S100B and Behcet disease: In our understanding, the patient's clinical condition should be the focus of evaluation; however, early (up to 24 hours) S100b levels could complement other complementary examinations in patients with acute brain injury, supporting clinical decision-making regarding the monitoring of neurocritical patients and prompt diagnosis of BD.